Navigation Links
Transcept Pharmaceuticals Reports Fourth Quarter and Year End 2008 Financial Results
Date:3/23/2009

Conference call scheduled at 5:00 PM Eastern Time today

Corporate Developments

- September 2008: Submitted the Intermezzo(R) new drug application (NDA) to the U.S. Food and Drug Administration (FDA)

- December 2008: FDA assigned a July 30, 2009 Prescription Drug User Fee Act (PDUFA) review date to the Intermezzo(R) NDA

- January 2009: Completed merger with Novacea, Inc. to create late-stage, publicly traded specialty pharmaceutical company with cash, cash equivalents and marketable securities at close estimated to be approximately $92 million

PT. RICHMOND, Calif., March 23 /PRNewswire-FirstCall/ -- Transcept Pharmaceuticals, Inc. (Nasdaq: TSPT), a specialty pharmaceutical company focused on the development and commercialization of proprietary products that address important therapeutic needs in neuroscience, today announced financial results for the quarter and year ended December 31, 2008.

Glenn A. Oclassen, President and Chief Executive Officer, commented, "We are pleased with the accomplishments the Transcept team achieved over the past year, in particular the January 30, 2009 merger with Novacea that has enhanced our capital position and provided Transcept with a public listing on NASDAQ. We believe our resources are now sufficient to enable Transcept to carry out its plans to commercialize Intermezzo(R), subject to FDA approval. Following the 2008 Intermezzo(R) NDA submission, the FDA assigned a July 30, 2009 PDUFA review date. If approved, Transcept believes that Intermezzo(R) will be the first prescription sleep aid approved for use in the middle of the night when patients awaken and have difficulty returning to sleep. We continue to focus on pre-commercialization activities, including ident
'/>"/>

SOURCE Transcept Pharmaceuticals, Inc.
Copyright©2009 PR Newswire.
All rights reserved

Page: 1 2 3 4 5 6 7 8 9 10 11 12

Related medicine news :

1. Transcept Pharmaceuticals to Report Fourth Quarter 2008 Results
2. Transcept Pharmaceuticals to Present at Two Upcoming Conferences
3. Transcept Pharmaceuticals, Inc. Completes Merger with Novacea, Inc.
4. Transcept Pharmaceuticals to Participate on Drug Delivery Investor Panel
5. Transcept Pharmaceuticals, Inc. to Present at the 20th Annual Piper Jaffray Health Care Conference
6. Transcept Pharmaceuticals to Present at the Jefferies 2nd Annual Healthcare Conference
7. Transcept Pharmaceuticals to Present at the BioCentury Future Leaders in the Biotech Industry Conference
8. Transcept Pharmaceuticals to Present at Cowen and Companys 27th Annual Health Care Conference in Boston
9. Transcept Pharmaceuticals to Present at the Susquehanna Financial Groups SIGnificant Investment Options in Healthcare Conference
10. Transcept Pharmaceuticals to Present at the 10th Annual BIO CEO & Investor Conference
11. Transcept Pharmaceuticals to Present at the 2008 Merrill Lynch Global Pharmaceutical, Biotechnology and Medical Device Conference
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:8/31/2015)... ... August 31, 2015 , ... ... and Organization Supporting Business Owners and provided a tour of their North American ... the success possible to international companies expanding business in the U.S. , ...
(Date:8/31/2015)... ... , ... ERT, a leading global provider of high-quality patient ... multiple prototypes from its Innovation Lab during its 8th Annual European PRO and ... event dedicated to providing case studies and pragmatic information on the clinical science, ...
(Date:8/31/2015)... ... August 31, 2015 , ... ... its first Digital Hub in North America, now open in Jacksonville, Florida. ... Founder and CEO John Campbell. “Jacksonville’s lifestyle, waterways and beautiful beaches fit perfectly ...
(Date:8/31/2015)... ... 31, 2015 , ... All birth control methods work best if used correctly ... among birth control methods. Moreover, no-scalpel vasectomy has many proven advantages with a lower ... vasectomy done because they are afraid of complications. , One Stop Medical Center ...
(Date:8/31/2015)... ... 31, 2015 , ... healthbeautydistributors.com has been in business since ... a doctor note service to be made available to all patients and family ... generated excuse, much less than the average daily pay of workers. , ...
Breaking Medicine News(10 mins):Health News:PartnerTech Supports Economic Growth as Host 2Health News:ERT to Demonstrate Innovation Lab Prototypes at European PRO / eCOA Congress 2Health News:ERT to Demonstrate Innovation Lab Prototypes at European PRO / eCOA Congress 3Health News:Global Digital Opens USA Digital Agency Hub 2Health News:One Stop Medical Center of Twin Cities Achieves Zero Failure Rate and Infection Rate in No Scalpel Vasectomy 2
... recent discovery of more than a thousand genes known ... a new approach to understanding the function and organization ... even more compelling with the finding that dozens of ... mutated gene in cancer), suggesting that this class of ...
... are likely the cause of the feminization of fish say ... of their study in the journal Environmental Toxicology and ... the huge geographical area we covered. We found that chemicals ... to harm fish were present along approximately 600 km of ...
... a family history of male breast cancer perceive themselves to ... patients with a family history of female breast cancer; however ... likely to know about or seek genetic testing than those ... a study led by researchers at the University of Louisville,s ...
... Amanda Gardner HealthDay Reporter , WEDNESDAY, July 28 (HealthDay ... grow an entire joint from stem cells, albeit in rabbits not ... hop and walk and bear weight, virtually like normal rabbits," said ... 29 in The Lancet . "This was the first regeneration ...
... of Stavanger (UiS), is set to help Norwegian nursing students ... words "drug calculationss" to a nursing student, it is likely ... it a difficult subject, the students also have to master ... to fail, which again bars you from working as a ...
... is available in French . , Often causing ... infects eight to ten million people every year, kills two ... through coughing and sneezing. "It,s a global health disaster waiting ... in TB research may offer an immediate opportunity to improve ...
Cached Medicine News:Health News:'Linc-ing' a noncoding RNA to a central cellular pathway 2Health News:Gender-bending fish on the rise in southern Alberta 2Health News:Male breast cancer in family leads to high perception of risk, low likelihood of genetic counseling 2Health News:Male breast cancer in family leads to high perception of risk, low likelihood of genetic counseling 3Health News:Scientists Use Stem Cells to Help Rabbits Grow New Joints 2Health News:Scientists Use Stem Cells to Help Rabbits Grow New Joints 3Health News:Playing with pills 2Health News:A breakthrough in tuberculosis research 2
(Date:8/29/2015)... 2015 La sofisticada aplicación ... sistemas de imagen por Ultrasonidos   ofrece resultados más ... rápidos y un flujo de trabajo   optimizado, lo ... proceso de detección de Cardiopatías   ... el lanzamiento europeo de HeartModel A.I ...
(Date:8/28/2015)... , Aug. 28, 2015  Delays in the ... can slow down the decision-making process, resulting in ... absolutely critical for biopharmaceutical companies to develop a ... process for quicker and more meaningful insights. ... Practices, LLC, nearly three-quarters of benchmarked study participants ...
(Date:8/28/2015)... 28, 2015 According to a ... (Breast, Lung, Prostate) Type (Protein & Genetic Biomarkers) Profiling ... Prognostic) & Geography - Global Forecast to 2020", published ... reach around 17,689.0 Million USD by 2020 at a ... to 2020. Browse 191 Tables and ...
Breaking Medicine Technology:Philips presenta HeartModel A.I en el Congreso ESC 2015 2Philips presenta HeartModel A.I en el Congreso ESC 2015 3Philips presenta HeartModel A.I en el Congreso ESC 2015 4Philips presenta HeartModel A.I en el Congreso ESC 2015 5Expediting the Pharmaceutical Market Research Process for Faster Insights 2Cancer Biomarkers Market Worth 17,689.0 Million USD by 2020 2Cancer Biomarkers Market Worth 17,689.0 Million USD by 2020 3Cancer Biomarkers Market Worth 17,689.0 Million USD by 2020 4Cancer Biomarkers Market Worth 17,689.0 Million USD by 2020 5
... , , STAMFORD, Conn., Jan. 8 ... (Nasdaq: SPDE ), today announced that Health Canada, ... the Zargis Cardioscan(TM) device for sale in Canada. , ... a Bluetooth®-enabled electronic stethoscope and is designed to help ...
... 8 Somanetics Corporation (Nasdaq: SMTS ) will release its ... 30, 2009 before the opening of the market on Thursday, January ... Company will host a conference call that will be webcast live ... On the conference call, Bruce Barrett, Somanetics, president and chief executive ...
Cached Medicine Technology:Zargis Cardioscan Cleared for Sale in Canada 2Zargis Cardioscan Cleared for Sale in Canada 3Somanetics Corporation to Release Fourth Quarter and Fiscal 2009 Financial Results and Host Conference Call January 21, 2010 2
The BD LSR II can be configured with up to four fixed alignment lasers and the ability to detect up to 15 colors, utilizing a revolutionary optical design. The BD LSR II can be configured with a 488 ...
Modular flow cytometer with all options....
... Ultracompact mobile/portable flow cytometer especially suited ... volumetric counting. The CyFlow allows to ... up to 2 fluorescence channels. Data ... performed with a built-in PC employing ...
... Compact mobile flow cytometer for ... absolute volumetric counting. The CyFlow SL ... in combination with up to 3 ... real-time display is performed with a ...
Medicine Products: